{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:17:41Z","timestamp":1790720261109,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["964874"],"award-info":[{"award-number":["964874"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009362","name":"South London and Maudsley NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MC_U120097115"],"award-info":[{"award-number":["MC_U120097115"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012176","name":"Maudsley Charity","doi-asserted-by":"publisher","award":["666"],"award-info":[{"award-number":["666"]}],"id":[{"id":"10.13039\/100012176","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["094849\/Z\/10\/Z"],"award-info":[{"award-number":["094849\/Z\/10\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1038\/s41386-025-02120-4","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T06:30:52Z","timestamp":1746599452000},"page":"1275-1283","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Antipsychotics cause reversible structural brain changes within one week"],"prefix":"10.1038","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9069-0700","authenticated-orcid":false,"given":"Pierluigi","family":"Selvaggi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5462-8464","authenticated-orcid":false,"given":"Martin","family":"Osugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uzma","family":"Zahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ottavia","family":"Dipasquale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7005-902X","authenticated-orcid":false,"given":"Thomas","family":"Whitehurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellis","family":"Onwordi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Finelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5118-7977","authenticated-orcid":false,"given":"Ben","family":"Statton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias C.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew B.","family":"Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0829-0519","authenticated-orcid":false,"given":"Robin","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1152-5323","authenticated-orcid":false,"given":"Mitul A.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0602-7661","authenticated-orcid":false,"given":"Tiago Reis","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2928-1972","authenticated-orcid":false,"given":"Oliver D.","family":"Howes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"key":"2120_CR1","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1001\/jamapsychiatry.2019.3360","volume":"77","author":"RA McCutcheon","year":"2020","unstructured":"McCutcheon RA, Reis Marques T, Howes OD. Schizophrenia-an overview. JAMA Psychiatry. 2020;77:201\u201310.","journal-title":"JAMA Psychiatry"},{"key":"2120_CR2","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","volume":"394","author":"M Huhn","year":"2019","unstructured":"Huhn M, Nikolakopoulou A, Schneider-Thoma J, Krause M, Samara M, Peter N, et al. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet. 2019;394:939\u201351.","journal-title":"Lancet"},{"key":"2120_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.107704","volume":"172","author":"SJ Kaar","year":"2020","unstructured":"Kaar SJ, Natesan S, McCutcheon R, Howes OD. Antipsychotics: Mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology. Neuropharmacology. 2020;172:107704.","journal-title":"Neuropharmacology"},{"key":"2120_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41386-022-01426-x","volume":"48","author":"OD Howes","year":"2023","unstructured":"Howes OD, Cummings C, Chapman GE, Shatalina E. Neuroimaging in schizophrenia: an overview of findings and their implications for synaptic changes. Neuropsychopharmacology. 2023;48:151\u201367.","journal-title":"Neuropsychopharmacology"},{"key":"2120_CR5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/wps.20516","volume":"17","author":"CU Correll","year":"2018","unstructured":"Correll CU, Rubio JM, Kane JM. What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia? World Psychiatry. 2018;17:149\u201360.","journal-title":"World Psychiatry"},{"key":"2120_CR6","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1177\/02698811221087645","volume":"36","author":"KN Fountoulakis","year":"2022","unstructured":"Fountoulakis KN, Stahl SM. The effect of first- and second-generation antipsychotics on brain morphology in schizophrenia: A systematic review of longitudinal magnetic resonance studies with a randomized allocation to treatment arms. J Psychopharmacol. 2022;36:428\u201338.","journal-title":"J Psychopharmacol"},{"key":"2120_CR7","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1177\/02698811221092252","volume":"36","author":"SM Lawrie","year":"2022","unstructured":"Lawrie SM. Do antipsychotic drugs shrink the brain? Probably not. J Psychopharmacol. 2022;36:425\u201327.","journal-title":"J Psychopharmacol"},{"key":"2120_CR8","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.neubiorev.2016.10.004","volume":"76","author":"D Amato","year":"2017","unstructured":"Amato D, Beasley CL, Hahn MK, Vernon AC. Neuroadaptations to antipsychotic drugs: Insights from pre-clinical and human post-mortem studies. Neurosci Biobehav Rev. 2017;76:317\u201335.","journal-title":"Neurosci Biobehav Rev"},{"key":"2120_CR9","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/schbul\/sbz119","volume":"46","author":"FE Turkheimer","year":"2020","unstructured":"Turkheimer FE, Selvaggi P, Mehta MA, Veronese M, Zelaya F, Dazzan P, et al. Normalizing the abnormal: do antipsychotic drugs push the cortex into an unsustainable metabolic envelope? Schizophr Bull. 2020;46:484\u201395.","journal-title":"Schizophr Bull"},{"key":"2120_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0893-133X(02)00287-7","volume":"27","author":"AnderssonC Hamer","year":"2002","unstructured":"Hamer AnderssonC, Lawler RM, Mailman CP, Lieberman RB. JA. Striatal volume changes in the rat following long-term administration of typical and atypical antipsychotic drugs. Neuropsychopharmacology. 2002;27:143\u201351.","journal-title":"Neuropsychopharmacology"},{"key":"2120_CR11","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.neuroimage.2018.04.054","volume":"176","author":"E Guma","year":"2018","unstructured":"Guma E, Rocchetti J, Devenyi GA, Tanti A, Mathieu A, Lerch JP, et al. Regional brain volume changes following chronic antipsychotic administration are mediated by the dopamine D2 receptor. Neuroimage. 2018;176:226\u201338.","journal-title":"Neuroimage"},{"key":"2120_CR12","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.biopsych.2011.12.004","volume":"71","author":"AC Vernon","year":"2012","unstructured":"Vernon AC, Natesan S, Crum WR, Cooper JD, Modo M, Williams SC, et al. Contrasting effects of haloperidol and lithium on rodent brain structure: a magnetic resonance imaging study with postmortem confirmation. Biol Psychiatry. 2012;71:855\u201363.","journal-title":"Biol Psychiatry"},{"key":"2120_CR13","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.biopsych.2010.11.010","volume":"69","author":"AC Vernon","year":"2011","unstructured":"Vernon AC, Natesan S, Modo M, Kapur S. Effect of chronic antipsychotic treatment on brain structure: a serial magnetic resonance imaging study with ex vivo and postmortem confirmation. Biol Psychiatry. 2011;69:936\u201344.","journal-title":"Biol Psychiatry"},{"key":"2120_CR14","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.pharep.2019.04.020","volume":"71","author":"E Drazanova","year":"2019","unstructured":"Drazanova E, Kratka L, Vaskovicova N, Skoupy R, Horska K, Babinska Z, et al. Olanzapine exposure diminishes perfusion and decreases volume of sensorimotor cortex in rats. Pharm Rep. 2019;71:839\u201347.","journal-title":"Pharm Rep"},{"key":"2120_CR15","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.biopsych.2013.09.012","volume":"75","author":"AC Vernon","year":"2014","unstructured":"Vernon AC, Crum WR, Lerch JP, Chege W, Natesan S, Modo M, et al. Reduced cortical volume and elevated astrocyte density in rats chronically treated with antipsychotic drugs-linking magnetic resonance imaging findings to cellular pathology. Biol Psychiatry. 2014;75:982\u201390.","journal-title":"Biol Psychiatry"},{"key":"2120_CR16","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/sj.npp.1300710","volume":"30","author":"KA Dorph-Petersen","year":"2005","unstructured":"Dorph-Petersen KA, Pierri JN, Perel JM, Sun Z, Sampson AR, Lewis DA. The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology. 2005;30:1649\u201361.","journal-title":"Neuropsychopharmacology"},{"key":"2120_CR17","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3389\/fnins.2020.00484","volume":"14","author":"HG Andersen","year":"2020","unstructured":"Andersen HG, Raghava JM, Svarer C, Wulff S, Johansen LB, Antonsen PK, et al. Striatal volume increase after six weeks of selective dopamine D(2\/3) receptor blockade in first-episode, antipsychotic-naive schizophrenia patients. Front Neurosci. 2020;14:484.","journal-title":"Front Neurosci"},{"key":"2120_CR18","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1176\/ajp.151.10.1430","volume":"151","author":"MH Chakos","year":"1994","unstructured":"Chakos MH, Lieberman JA, Bilder RM, Borenstein M, Lerner G, Bogerts B, et al. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry. 1994;151:1430\u20136.","journal-title":"Am J Psychiatry"},{"key":"2120_CR19","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/sj.npp.1300603","volume":"30","author":"P Dazzan","year":"2005","unstructured":"Dazzan P, Morgan KD, Orr K, Hutchinson G, Chitnis X, Suckling J, et al. Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study. Neuropsychopharmacology. 2005;30:765\u201374.","journal-title":"Neuropsychopharmacology"},{"key":"2120_CR20","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/S0140-6736(94)90599-1","volume":"344","author":"MS Keshavan","year":"1994","unstructured":"Keshavan MS, Bagwell WW, Haas GL, Sweeney JA, Schooler NR, Pettegrew JW. Changes in caudate volume with neuroleptic treatment. Lancet. 1994;344:1434.","journal-title":"Lancet"},{"key":"2120_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1001\/archpsyc.62.4.361","volume":"62","author":"JA Lieberman","year":"2005","unstructured":"Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, Kahn RS, et al. Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry. 2005;62:361\u201370.","journal-title":"Arch Gen Psychiatry"},{"key":"2120_CR22","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.neubiorev.2013.06.001","volume":"37","author":"P Fusar-Poli","year":"2013","unstructured":"Fusar-Poli P, Smieskova R, Kempton MJ, Ho BC, Andreasen NC, Borgwardt S. Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies. Neurosci Biobehav Rev. 2013;37:1680\u201391.","journal-title":"Neurosci Biobehav Rev"},{"key":"2120_CR23","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1093\/schbul\/sbs118","volume":"39","author":"SV Haijma","year":"2013","unstructured":"Haijma SV, Van Haren N, Cahn W, Koolschijn PC, Hulshoff Pol HE, Kahn RS. Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects. Schizophr Bull. 2013;39:1129\u201338.","journal-title":"Schizophr Bull"},{"key":"2120_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pscychresns.2017.05.009","volume":"266","author":"S Huhtaniska","year":"2017","unstructured":"Huhtaniska S, Jaaskelainen E, Heikka T, Moilanen JS, Lehtiniemi H, Tohka J, et al. Long-term antipsychotic and benzodiazepine use and brain volume changes in schizophrenia: The Northern Finland Birth Cohort 1966 study. Psychiatry Res Neuroimaging. 2017;266:73\u201382.","journal-title":"Psychiatry Res Neuroimaging"},{"key":"2120_CR25","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.biopsych.2018.04.023","volume":"84","author":"TGM van Erp","year":"2018","unstructured":"van Erp TGM, Walton E, Hibar DP, Schmaal L, Jiang W, Glahn DC, et al. Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium. Biol Psychiatry. 2018;84:644\u201354.","journal-title":"Biol Psychiatry"},{"key":"2120_CR26","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1176\/appi.ajp.2013.12050674","volume":"170","author":"NC Andreasen","year":"2013","unstructured":"Andreasen NC, Liu D, Ziebell S, Vora A, Ho BC. Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study. Am J Psychiatry. 2013;170:609\u201315.","journal-title":"Am J Psychiatry"},{"key":"2120_CR27","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1001\/archgenpsychiatry.2010.199","volume":"68","author":"BC Ho","year":"2011","unstructured":"Ho BC, Andreasen NC, Ziebell S, Pierson R, Magnotta V. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry. 2011;68:128\u201337.","journal-title":"Arch Gen Psychiatry"},{"key":"2120_CR28","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1017\/S0033291709992297","volume":"40","author":"J Moncrieff","year":"2010","unstructured":"Moncrieff J, Leo J. A systematic review of the effects of antipsychotic drugs on brain volume. Psychol Med. 2010;40:1409\u201322.","journal-title":"Psychol Med"},{"key":"2120_CR29","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1017\/S0033291709005315","volume":"39","author":"S Navari","year":"2009","unstructured":"Navari S, Dazzan P. Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings. Psychol Med. 2009;39:1763\u201377.","journal-title":"Psychol Med"},{"key":"2120_CR30","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.2174\/138161209788957456","volume":"15","author":"R Smieskova","year":"2009","unstructured":"Smieskova R, Fusar-Poli P, Allen P, Bendfeldt K, Stieglitz RD, Drewe J, et al. The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia?-a systematic review. Curr Pharm Des. 2009;15:2535\u201349.","journal-title":"Curr Pharm Des"},{"key":"2120_CR31","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1177\/2045125318782306","volume":"8","author":"SM Lawrie","year":"2018","unstructured":"Lawrie SM. Are structural brain changes in schizophrenia related to antipsychotic medication? A narrative review of the evidence from a clinical perspective. Ther Adv Psychopharmacol. 2018;8:319\u201326.","journal-title":"Ther Adv Psychopharmacol"},{"key":"2120_CR32","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/nn.2572","volume":"13","author":"H Tost","year":"2010","unstructured":"Tost H, Braus DF, Hakimi S, Ruf M, Vollmert C, Hohn F, et al. Acute D2 receptor blockade induces rapid, reversible remodeling in human cortical-striatal circuits. Nat Neurosci. 2010;13:920\u20132.","journal-title":"Nat Neurosci"},{"key":"2120_CR33","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/hbm.23844","volume":"39","author":"PCT Hawkins","year":"2018","unstructured":"Hawkins PCT, Wood TC, Vernon AC, Bertolino A, Sambataro F, Dukart J, et al. An investigation of regional cerebral blood flow and tissue structure changes after acute administration of antipsychotics in healthy male volunteers. Hum Brain Mapp. 2018;39:319\u201331.","journal-title":"Hum Brain Mapp"},{"key":"2120_CR34","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1002\/hbm.23137","volume":"37","author":"S Lorio","year":"2016","unstructured":"Lorio S, Kherif F, Ruef A, Melie-Garcia L, Frackowiak R, Ashburner J, et al. Neurobiological origin of spurious brain morphological changes: A quantitative MRI study. Hum Brain Mapp. 2016;37:1801\u201315.","journal-title":"Hum Brain Mapp"},{"key":"2120_CR35","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/WCO.0000000000000222","volume":"28","author":"N Weiskopf","year":"2015","unstructured":"Weiskopf N, Mohammadi S, Lutti A, Callaghan MF. Advances in MRI-based computational neuroanatomy: from morphometry to in-vivo histology. Curr Opin Neurol. 2015;28:313\u201322.","journal-title":"Curr Opin Neurol"},{"key":"2120_CR36","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.neuroimage.2009.10.002","volume":"49","author":"JP Marques","year":"2010","unstructured":"Marques JP, Kober T, Krueger G, van der Zwaag W, Van de Moortele PF, Gruetter R. MP2RAGE, a self bias-field corrected sequence for improved segmentation and T1-mapping at high field. Neuroimage. 2010;49:1271\u201381.","journal-title":"Neuroimage"},{"key":"2120_CR37","doi-asserted-by":"crossref","unstructured":"Taylor D, Barnes TRE, Young A The Maudsley prescribing guidelines in psychiatry. 14th edition \/ ed. Wiley Blackwell: Hoboken, NJ; 2021.","DOI":"10.1002\/9781119870203"},{"key":"2120_CR38","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1097\/JCP.0b013e3182983ffa","volume":"33","author":"IM Lako","year":"2013","unstructured":"Lako IM, van den Heuvel ER, Knegtering H, Bruggeman R, Taxis K. Estimating dopamine D(2) receptor occupancy for doses of 8 antipsychotics: a meta-analysis. J Clin Psychopharmacol. 2013;33:675\u201381.","journal-title":"J Clin Psychopharmacol"},{"key":"2120_CR39","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1006\/nimg.1998.0395","volume":"9","author":"AM Dale","year":"1999","unstructured":"Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage. 1999;9:179\u201394.","journal-title":"Neuroimage"},{"key":"2120_CR40","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","volume":"31","author":"RS Desikan","year":"2006","unstructured":"Desikan RS, Segonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 2006;31:968\u201380.","journal-title":"Neuroimage"},{"key":"2120_CR41","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0896-6273(02)00569-X","volume":"33","author":"B Fischl","year":"2002","unstructured":"Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002;33:341\u201355.","journal-title":"Neuron"},{"key":"2120_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56663-7","volume":"16","author":"M Osugo","year":"2025","unstructured":"Osugo M, Wall MB, Selvaggi P, Zahid U, Finelli V, Chapman GE, et al. Striatal dopamine D2\/D3 receptor regulation of human reward processing and behaviour. Nat Commun. 2025;16:1852.","journal-title":"Nat Commun"},{"key":"2120_CR43","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1038\/s41386-021-00980-0","volume":"46","author":"S Chopra","year":"2021","unstructured":"Chopra S, Fornito A, Francey SM, O\u2019Donoghue B, Cropley V, Nelson B, et al. Differentiating the effect of antipsychotic medication and illness on brain volume reductions in first-episode psychosis: A Longitudinal, Randomised, Triple-blind, Placebo-controlled MRI Study. Neuropsychopharmacology. 2021;46:1494\u2013501.","journal-title":"Neuropsychopharmacology"},{"key":"2120_CR44","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1001\/jamapsychiatry.2020.0036","volume":"77","author":"AN Voineskos","year":"2020","unstructured":"Voineskos AN, Mulsant BH, Dickie EW, Neufeld NH, Rothschild AJ, Whyte EM, et al. Effects of antipsychotic medication on brain structure in patients with major depressive disorder and psychotic features: neuroimaging findings in the context of a randomized placebo-controlled clinical trial. JAMA Psychiatry. 2020;77:674\u201383.","journal-title":"JAMA Psychiatry"},{"key":"2120_CR45","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0306-4522(89)90179-6","volume":"28","author":"M Camps","year":"1989","unstructured":"Camps M, Cortes R, Gueye B, Probst A, Palacios JM. Dopamine receptors in human brain: autoradiographic distribution of D2 sites. Neuroscience. 1989;28:275\u201390.","journal-title":"Neuroscience"},{"key":"2120_CR46","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.neubiorev.2021.11.032","volume":"132","author":"MC Lobo","year":"2022","unstructured":"Lobo MC, Whitehurst TS, Kaar SJ, Howes OD. New and emerging treatments for schizophrenia: a narrative review of their pharmacology, efficacy and side effect profile relative to established antipsychotics. Neurosci Biobehav R. 2022;132:324\u201361.","journal-title":"Neurosci Biobehav R"},{"key":"2120_CR47","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.neuroimage.2018.12.028","volume":"188","author":"P Selvaggi","year":"2019","unstructured":"Selvaggi P, Hawkins PCT, Dipasquale O, Rizzo G, Bertolino A, Dukart J, et al. Increased cerebral blood flow after single dose of antipsychotics in healthy volunteers depends on dopamine D2 receptor density profiles. Neuroimage. 2019;188:774\u201384.","journal-title":"Neuroimage"},{"key":"2120_CR48","doi-asserted-by":"publisher","first-page":"11169","DOI":"10.1073\/pnas.1220512110","volume":"110","author":"CY Sander","year":"2013","unstructured":"Sander CY, Hooker JM, Catana C, Normandin MD, Alpert NM, Knudsen GM, et al. Neurovascular coupling to D2\/D3 dopamine receptor occupancy using simultaneous PET\/functional MRI. Proc Natl Acad Sci USA. 2013;110:11169\u201374.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2120_CR49","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1093\/schbul\/sbv037","volume":"41","author":"S Leucht","year":"2015","unstructured":"Leucht S, Samara M, Heres S, Patel MX, Furukawa T, Cipriani A, et al. Dose equivalents for second-generation antipsychotic drugs: the classical mean dose method. Schizophr Bull. 2015;41:1397\u2013402.","journal-title":"Schizophr Bull"},{"key":"2120_CR50","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1055\/s-0037-1600991","volume":"51","author":"C Hiemke","year":"2018","unstructured":"Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, et al. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry. 2018;51:e1.","journal-title":"Pharmacopsychiatry"},{"key":"2120_CR51","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.neuroimage.2014.02.026","volume":"93","author":"C Stuber","year":"2014","unstructured":"Stuber C, Morawski M, Schafer A, Labadie C, Wahnert M, Leuze C, et al. Myelin and iron concentration in the human brain: a quantitative study of MRI contrast. Neuroimage. 2014;93:95\u2013106.","journal-title":"Neuroimage"},{"key":"2120_CR52","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.biopsych.2012.09.029","volume":"73","author":"DA Cousins","year":"2013","unstructured":"Cousins DA, Aribisala B, Nicol Ferrier I, Blamire AM. Lithium, gray matter, and magnetic resonance imaging signal. Biol Psychiatry. 2013;73:652\u20137.","journal-title":"Biol Psychiatry"},{"key":"2120_CR53","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/978-1-61737-992-5_4","volume":"711","author":"SC Deoni","year":"2011","unstructured":"Deoni SC. Magnetic resonance relaxation and quantitative measurement in the brain. Methods Mol Biol. 2011;711:65\u2013108.","journal-title":"Methods Mol Biol"},{"key":"2120_CR54","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00429-012-0385-6","volume":"218","author":"TR Franklin","year":"2013","unstructured":"Franklin TR, Wang Z, Shin J, Jagannathan K, Suh JJ, Detre JA, et al. A VBM study demonstrating \u2018apparent\u2019 effects of a single dose of medication on T1-weighted MRIs. Brain Struct Funct. 2013;218:97\u2013104.","journal-title":"Brain Struct Funct"},{"key":"2120_CR55","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/j.1365-2125.2006.02695.x","volume":"62","author":"P Salgado-Pineda","year":"2006","unstructured":"Salgado-Pineda P, Delaveau P, Falcon C, Blin O. Brain T1 intensity changes after levodopa administration in healthy subjects: a voxel-based morphometry study. Br J Clin Pharm. 2006;62:546\u201351.","journal-title":"Br J Clin Pharm"},{"key":"2120_CR56","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1001\/jamapsychiatry.2020.1941","volume":"78","author":"DR Weinberger","year":"2021","unstructured":"Weinberger DR, Radulescu E. Structural magnetic resonance imaging all over again. JAMA Psychiatry. 2021;78:11\u201312.","journal-title":"JAMA Psychiatry"},{"key":"2120_CR57","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1038\/s41380-022-01509-7","volume":"27","author":"A Abrantes","year":"2022","unstructured":"Abrantes A, Giusti-Rodriguez P, Ancalade N, Sekle S, Basiri ML, Stuber GD, et al. Gene expression changes following chronic antipsychotic exposure in single cells from mouse striatum. Mol Psychiatry. 2022;27:2803\u201312.","journal-title":"Mol Psychiatry"},{"key":"2120_CR58","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S0301-0082(99)00064-7","volume":"61","author":"OA Andreassen","year":"2000","unstructured":"Andreassen OA, Jorgensen HA. Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats - Implications for tardive dyskinesia? Prog Neurobiol. 2000;61:525\u201341.","journal-title":"Prog Neurobiol"},{"key":"2120_CR59","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ejphar.2003.08.018","volume":"477","author":"RE McCullumsmith","year":"2003","unstructured":"McCullumsmith RE, Stincic TL, Agrawal SM, Meador-Woodruff JH. Differential effects of antipsychotics on haloperidol-induced vacuous chewing movements and subcortical gene expression in the rat. Eur J Pharm. 2003;477:101\u201312.","journal-title":"Eur J Pharm"},{"key":"2120_CR60","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1176\/appi.ajp.2015.15060753","volume":"173","author":"DR Weinberger","year":"2016","unstructured":"Weinberger DR, Radulescu E. Finding the elusive psychiatric \u201clesion\u201d with 21st-century neuroanatomy: a note of caution. Am J Psychiatry. 2016;173:27\u201333.","journal-title":"Am J Psychiatry"},{"key":"2120_CR61","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/mp.2015.118","volume":"21","author":"TG van Erp","year":"2016","unstructured":"van Erp TG, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA, et al. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry. 2016;21:585.","journal-title":"Mol Psychiatry"},{"key":"2120_CR62","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1001\/jamapsychiatry.2017.2663","volume":"74","author":"SP Brugger","year":"2017","unstructured":"Brugger SP, Howes OD. Heterogeneity and homogeneity of regional brain structure in schizophrenia: a meta-analysis. JAMA Psychiatry. 2017;74:1104\u201311.","journal-title":"JAMA Psychiatry"},{"key":"2120_CR63","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1038\/s41380-023-02043-w","volume":"28","author":"OD Howes","year":"2023","unstructured":"Howes OD, Onwordi EC. The synaptic hypothesis of schizophrenia version III: a master mechanism. Mol Psychiatry. 2023;28:1843\u201356.","journal-title":"Mol Psychiatry"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02120-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02120-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02120-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T09:02:55Z","timestamp":1750064575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02120-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":63,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["2120"],"URL":"https:\/\/doi.org\/10.1038\/s41386-025-02120-4","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,7]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the past three years, MAM has been an advisory board member for Lundbeck and Forum Pharmaceuticals. He also received research funding from Lundbeck, Takeda, and Johnson & Johnson. O.D.H. has received investigator-initiated research funding from and\/or participated in advisory\/speaker meetings organized by Angellini, Autifony, Biogen, Boehringer-Ingelheim, Eli Lilly, Elysium, Heptares, Global Medical Education, Invicro, Jansenn, Karuna, Lundbeck, Merck, Neurocrine, Ontrack\/ Pangea, Otsuka, Sunovion, Recordati, Roche, Rovi and Viatris\/Mylan. He was previously a part-time employee of Lundbeck A\/v. Neither O.D.H. nor his family have holdings\/a financial stake in any pharmaceutical company. ODH has a patent for the use of dopaminergic imaging. PS participated in advisory\/speaker meetings organized by Angelini and Lundbeck. M.B.W. is an employee of Perceptive Inc., London. T.R.M. is an employee and founder of Pasithea Therapeutics. Other authors have reported no biomedical financial interests or potential conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}